•Leadership watch: Samsara, Claris Bio, Staar Surgical, Wills Eye, and more•Study: Earlier RD surgery predicts stronger visual outcomes•Alcon introduces UNITY M ophthalmic microscope•Bausch + Lomb debuts IOL Compass framework for premium lens decisions•Sightview launches EHR, PM platform for ophthalmologists•Leadership watch: Samsara, Claris Bio, Staar Surgical, Wills Eye, and more•Study: Earlier RD surgery predicts stronger visual outcomes•Alcon introduces UNITY M ophthalmic microscope•Bausch + Lomb debuts IOL Compass framework for premium lens decisions•Sightview launches EHR, PM platform for ophthalmologists
HEADLINES
FEATURED
The newly-renamed MOGENRY could become the first gene-agnostic treatment for patients with RP having severe vision loss.
Earn FREE CE 24/7 with Courses by Eyes On Eyecare
Explore premium-quality, bite-sized courses featuring leading experts like Cecelia Koetting, OD, FAAO, and Cory Lappin, OD, MS, FAAO, and continuing education covering topics from ocular rosacea treatments to retinal disease.
